NIOX Group (LON:NIOX) Releases Earnings Results

NIOX Group (LON:NIOX) issued its quarterly earnings data on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.37% and a return on equity of 10.14%.

NIOX Group Price Performance

LON NIOX traded up GBX 1 during trading hours on Wednesday, reaching GBX 69. The company’s stock had a trading volume of 792,778 shares, compared to its average volume of 803,933. The company has a debt-to-equity ratio of 1.36, a current ratio of 3.81 and a quick ratio of 1.94. The firm has a market capitalization of £290.40 million, a price-to-earnings ratio of 42.07 and a beta of 0.92. The company’s 50-day moving average is GBX 65.54 and its two-hundred day moving average is GBX 61.58. NIOX Group has a 1-year low of GBX 53.84 and a 1-year high of GBX 76.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.